Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M
Int J Nanomedicine. 2024; 19:12421-12438.
PMID: 39600411
PMC: 11590659.
DOI: 10.2147/IJN.S483626.
Hou W, Shen L, Zhu Y, Wang X, Du T, Yang F
Int J Nanomedicine. 2024; 19:9771-9797.
PMID: 39345909
PMC: 11430870.
DOI: 10.2147/IJN.S476601.
Teranishi K, Wagatsuma K, Toda K, Nomaru H, Yanagihashi Y, Ochiai H
Sci Rep. 2024; 14(1):21848.
PMID: 39300150
PMC: 11413197.
DOI: 10.1038/s41598-024-72016-8.
Kulesza A, Couty C, Lemarre P, Thalhauser C, Cao Y
J Pharmacokinet Pharmacodyn. 2024; 51(6):581-604.
PMID: 38904912
PMC: 11795844.
DOI: 10.1007/s10928-024-09930-x.
Guo J, Ma Y, Tang T, Bian Z, Li Q, Tang L
J Cancer. 2024; 15(6):1523-1535.
PMID: 38370371
PMC: 10869985.
DOI: 10.7150/jca.89120.
Downstaging and laparoscopic hepatectomy plus intraoperative radiofrequency ablation for the treatment of initially unresectable multifocal hepatocellular carcinomas.
Wang J, Luo H, Yi L, Yang P, Zeng X
Front Surg. 2024; 10:1340657.
PMID: 38283063
PMC: 10811958.
DOI: 10.3389/fsurg.2023.1340657.
Non-invasive PD-L1 quantification using [F]DK222-PET imaging in cancer immunotherapy.
Mishra A, Gupta K, Kumar D, Lofland G, Sharma A, Solnes L
J Immunother Cancer. 2023; 11(10).
PMID: 37793856
PMC: 10551964.
DOI: 10.1136/jitc-2023-007535.
In Situ Cocktail Nanovaccine for Cancer Immunotherapy.
Liu M, Xie D, Hu D, Zhang R, Wang Y, Tang L
Adv Sci (Weinh). 2023; 10(31):e2207697.
PMID: 37740439
PMC: 10625102.
DOI: 10.1002/advs.202207697.
The role of clinical imaging in oncology drug development: progress and new challenges.
Murphy P, Galette P, Van der Aart J, Janiczek R, Patel N, Brown A
Br J Radiol. 2023; 96(1150):20211126.
PMID: 37393537
PMC: 10546429.
DOI: 10.1259/bjr.20211126.
Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma.
Wang Y, Xiang X, Chen H, Zhou L, Chen S, Zhang G
Cell Rep Med. 2023; 4(5):101044.
PMID: 37196629
PMC: 10213871.
DOI: 10.1016/j.xcrm.2023.101044.
Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma.
Beck R, Sloot S, Matsushita H, Kakimi K, Beltman J
iScience. 2023; 26(5):106666.
PMID: 37182110
PMC: 10173735.
DOI: 10.1016/j.isci.2023.106666.
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Mundi P, Dela Cruz F, Grunn A, Diolaiti D, Mauguen A, Rainey A
Cancer Discov. 2023; 13(6):1386-1407.
PMID: 37061969
PMC: 10239356.
DOI: 10.1158/2159-8290.CD-22-1020.
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer.
Chen H, Cresswell G, Libring S, Ayers M, Miao J, Zhang Z
Cancer Res Commun. 2023; 2(10):1104-1118.
PMID: 36969745
PMC: 10035406.
DOI: 10.1158/2767-9764.CRC-22-0117.
Massively parallel knock-in engineering of human T cells.
Dai X, Park J, Du Y, Na Z, Lam S, Chow R
Nat Biotechnol. 2023; 41(9):1239-1255.
PMID: 36702900
PMC: 11260498.
DOI: 10.1038/s41587-022-01639-x.
Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance.
Voronova V, Vislobokova A, Mutig K, Samsonov M, Peskov K, Sekacheva M
Front Oncol. 2022; 12:1035884.
PMID: 36544712
PMC: 9760959.
DOI: 10.3389/fonc.2022.1035884.
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank).
Low J, Huang Y, Sooi K, Chan Z, Yong W, Lee S
Front Oncol. 2022; 12:932212.
PMID: 36465401
PMC: 9714462.
DOI: 10.3389/fonc.2022.932212.
Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds.
Radanovic I, Klarenbeek N, Rissmann R, Groeneveld G, van Brummelen E, Moerland M
Front Oncol. 2022; 12:954806.
PMID: 36106110
PMC: 9465458.
DOI: 10.3389/fonc.2022.954806.
CRISPR Screens to Identify Regulators of Tumor Immunity.
LaFleur M, Sharpe A
Annu Rev Cancer Biol. 2022; 6:103-122.
PMID: 35989706
PMC: 9389862.
DOI: 10.1146/annurev-cancerbio-070120-094725.
Translating MSC Therapy in the Age of Obesity.
Boland L, Bitterlich L, Hogan A, Ankrum J, English K
Front Immunol. 2022; 13:943333.
PMID: 35860241
PMC: 9289617.
DOI: 10.3389/fimmu.2022.943333.
A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy.
Tiu C, Shinde R, Pal A, Biondo A, Lee A, Tunariu N
J Immunother Precis Oncol. 2022; 4(4):189-195.
PMID: 35665022
PMC: 9138480.
DOI: 10.36401/JIPO-21-9.
